Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E3DF
|
|||
Former ID |
DNC014159
|
|||
Drug Name |
(2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine
|
|||
Synonyms |
CHEMBL568336; (2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H18INO2
|
|||
Canonical SMILES |
C1COC(CN1)C(C2=CC=CC=C2)OC3=CC=CC=C3I
|
|||
InChI |
1S/C17H18INO2/c18-14-8-4-5-9-15(14)21-17(13-6-2-1-3-7-13)16-12-19-10-11-20-16/h1-9,16-17,19H,10-12H2/t16-,17+/m1/s1
|
|||
InChIKey |
BHMLFPOTZYRDKA-SJORKVTESA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter. Bioorg Med Chem Lett. 2009 Sep 1;19(17):4996-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.